phosphatidylcholines has been researched along with gw9662 in 1 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (gw9662) | Trials (gw9662) | Recent Studies (post-2010) (gw9662) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 617 | 0 | 406 |
Protein | Taxonomy | phosphatidylcholines (IC50) | gw9662 (IC50) |
---|---|---|---|
Peroxisome proliferator-activated receptor gamma | Homo sapiens (human) | 3.3 | |
Nuclear receptor ROR-gamma | Homo sapiens (human) | 0.086 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ravinder, R; Singh, D; Yenuganti, VR | 1 |
1 other study(ies) available for phosphatidylcholines and gw9662
Article | Year |
---|---|
Conjugated linoleic acids attenuate LPS-induced pro-inflammatory gene expression by inhibiting the NF-κB translocation through PPARγ in buffalo granulosa cells.
Topics: Anilides; Animals; Anti-Inflammatory Agents; Buffaloes; Cells, Cultured; Cytokines; Female; Gene Expression; Granulosa Cells; Linoleic Acids, Conjugated; Lipopolysaccharides; NF-kappa B; Phosphatidylcholines; PPAR gamma; Toll-Like Receptor 4 | 2014 |